{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 3,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 2
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 → ¬A2)",
        "prover9_expression": "(approved(drug_x) -> -marketed(drug_x))",
        "natural": "Provided that drug X is approved, drug X is not marketed."
      },
      {
        "id": "Rule2",
        "formal": "(A11 → A12)",
        "prover9_expression": "(orphan_drug_designation(drug_x) -> rare_disease_indication(drug_x))",
        "natural": "In cases where drug X has orphan drug designation, drug X has a rare disease indication."
      },
      {
        "id": "Rule3",
        "formal": "(A12 → (A3 → (A1 → A2)))",
        "prover9_expression": "(rare_disease_indication(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Given that drug X has a rare disease indication, then whenever the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
      },
      {
        "id": "Rule4",
        "formal": "(A4 → (A3 → (A1 → A2)))",
        "prover9_expression": "(fda_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "If FDA review of drug X is conducted, then provided the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed."
      },
      {
        "id": "Rule5",
        "formal": "(A4 ∨ A5)",
        "prover9_expression": "(fda_review(drug_x) | fast_track_designation(drug_x))",
        "natural": "Either FDA review of drug X is conducted or drug X has fast track designation."
      },
      {
        "id": "Rule6",
        "formal": "(A5 → A11)",
        "prover9_expression": "(fast_track_designation(drug_x) -> orphan_drug_designation(drug_x))",
        "natural": "Provided that drug X has fast track designation, drug X has orphan drug designation."
      },
      {
        "id": "Rule7",
        "formal": "(A5 → A6)",
        "prover9_expression": "(fast_track_designation(drug_x) -> priority_review(drug_x))",
        "natural": "In cases where drug X has fast track designation, drug X has priority review."
      },
      {
        "id": "Rule8",
        "formal": "(A6 → (A3 → (A1 → A2)))",
        "prover9_expression": "(priority_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Should drug X have priority review, then if the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed."
      },
      {
        "id": "Rule9",
        "formal": "(A7 → (A3 → (A1 → A2)))",
        "prover9_expression": "(accelerated_approval(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Whenever drug X has accelerated approval, then provided the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
      },
      {
        "id": "Rule10",
        "formal": "(A8 → A7)",
        "prover9_expression": "(breakthrough_therapy(drug_x) -> accelerated_approval(drug_x))",
        "natural": "If drug X has breakthrough therapy designation, then drug X has accelerated approval."
      },
      {
        "id": "Rule11",
        "formal": "(A9 → A10)",
        "prover9_expression": "(standard_review(drug_x) -> complete_response(drug_x))",
        "natural": "Provided that drug X has standard review, drug X has a complete response."
      },
      {
        "id": "Rule12",
        "formal": "(¬(A5 → A8) → A9)",
        "prover9_expression": "(-(fast_track_designation(drug_x) -> breakthrough_therapy(drug_x)) -> standard_review(drug_x))",
        "natural": "If it is not the case that fast track designation of drug X implies breakthrough therapy designation, then drug X has standard review."
      },
      {
        "id": "Rule13",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-manufacturing_compliant(drug_x) -> approved(drug_x))",
        "natural": "In the event that drug X is not manufacturing compliant, drug X is approved."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A3",
        "prover9_expression": "clinical_trial_complete(drug_x)",
        "natural": "The clinical trial for drug X is complete."
      },
      {
        "id": "Fact2",
        "formal": "¬A10",
        "prover9_expression": "-complete_response(drug_x)",
        "natural": "Drug X does not have a complete response."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "manufacturing_compliant(drug_x)",
    "natural": "Drug X is manufacturing compliant."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A6)",
            "(A6 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A5 -> (A3 -> (A1 -> A2)))",
          "natural": "Whenever drug X has fast track designation, then if the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A4 | A5)",
            "(A4 -> (A3 -> (A1 -> A2)))",
            "(A5 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A3 -> (A1 -> A2))",
          "natural": "Should the clinical trial for drug X be complete, then if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> (A1 -> A2))",
            "A3"
          ],
          "conclusion": "(A1 -> A2)",
          "natural": "If drug X is approved, then drug X is marketed."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A1 -> A2)",
            "(A1 -> -A2)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is manufacturing compliant."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(A9 -> A10)",
            "-A10"
          ],
          "conclusion": "-A9",
          "natural": "Drug X does not have standard review."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A5 -> A8) -> A9)",
            "-A9"
          ],
          "conclusion": "(A5 -> A8)",
          "natural": "Given that drug X has fast track designation, drug X has breakthrough therapy designation."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A8)",
            "(A8 -> A7)"
          ],
          "conclusion": "(A5 -> A7)",
          "natural": "If drug X has fast track designation, then drug X has accelerated approval."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A7)",
            "(A7 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A5 -> (A3 -> (A1 -> A2)))",
          "natural": "Whenever drug X has fast track designation, then if the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A4 | A5)",
            "(A4 -> (A3 -> (A1 -> A2)))",
            "(A5 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A3 -> (A1 -> A2))",
          "natural": "Should the clinical trial for drug X be complete, then if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> (A1 -> A2))",
            "A3"
          ],
          "conclusion": "(A1 -> A2)",
          "natural": "If drug X is approved, then drug X is marketed."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(A1 -> A2)",
            "(A1 -> -A2)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 8,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is manufacturing compliant."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A11 -> A12)",
            "(A12 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A11 -> (A3 -> (A1 -> A2)))",
          "natural": "Whenever drug X has orphan drug designation, then if the clinical trial for drug X is complete, it follows that if drug X is approved, then drug X is marketed."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A11)",
            "(A11 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A5 -> (A3 -> (A1 -> A2)))",
          "natural": "Whenever drug X has fast track designation, then if the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A4 | A5)",
            "(A4 -> (A3 -> (A1 -> A2)))",
            "(A5 -> (A3 -> (A1 -> A2)))"
          ],
          "conclusion": "(A3 -> (A1 -> A2))",
          "natural": "Should the clinical trial for drug X be complete, then if drug X is approved, drug X is marketed."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A3 -> (A1 -> A2))",
            "A3"
          ],
          "conclusion": "(A1 -> A2)",
          "natural": "If drug X is approved, then drug X is marketed."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(A1 -> A2)",
            "(A1 -> -A2)"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that drug X is approved."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "Drug X is manufacturing compliant."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Regulatory Approval",
    "atomic_facts": {
      "A1": "approved(drug_x)",
      "A2": "marketed(drug_x)",
      "A3": "clinical_trial_complete(drug_x)",
      "A4": "fda_review(drug_x)",
      "A5": "fast_track_designation(drug_x)",
      "A6": "priority_review(drug_x)",
      "A7": "accelerated_approval(drug_x)",
      "A8": "breakthrough_therapy(drug_x)",
      "A9": "standard_review(drug_x)",
      "A10": "complete_response(drug_x)",
      "A11": "orphan_drug_designation(drug_x)",
      "A12": "rare_disease_indication(drug_x)",
      "G": "manufacturing_compliant(drug_x)"
    },
    "natural_facts": {
      "A1": "Drug X is approved.",
      "A2": "Drug X is marketed.",
      "A3": "Clinical trial for drug X is complete.",
      "A4": "FDA review of drug X is conducted.",
      "A5": "Drug X has fast track designation.",
      "A6": "Drug X has priority review.",
      "A7": "Drug X has accelerated approval.",
      "A8": "Drug X has breakthrough therapy designation.",
      "A9": "Drug X has standard review.",
      "A10": "Drug X has a complete response.",
      "A11": "Drug X has orphan drug designation.",
      "A12": "Drug X has a rare disease indication.",
      "G": "Drug X is manufacturing compliant."
    },
    "prover9_expressions": [
      "(approved(drug_x) -> marketed(drug_x))",
      "(approved(drug_x) -> -marketed(drug_x))",
      "(orphan_drug_designation(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(orphan_drug_designation(drug_x) -> rare_disease_indication(drug_x))",
      "(rare_disease_indication(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x)))",
      "(fda_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(fda_review(drug_x) | fast_track_designation(drug_x))",
      "(fast_track_designation(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(fast_track_designation(drug_x) -> orphan_drug_designation(drug_x))",
      "(fast_track_designation(drug_x) -> priority_review(drug_x))",
      "(fast_track_designation(drug_x) -> accelerated_approval(drug_x))",
      "(fast_track_designation(drug_x) -> breakthrough_therapy(drug_x))",
      "(priority_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(accelerated_approval(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
      "(breakthrough_therapy(drug_x) -> accelerated_approval(drug_x))",
      "(standard_review(drug_x) -> complete_response(drug_x))",
      "(-(fast_track_designation(drug_x) -> breakthrough_therapy(drug_x)) -> standard_review(drug_x))",
      "(-manufacturing_compliant(drug_x) -> approved(drug_x))",
      "clinical_trial_complete(drug_x)",
      "manufacturing_compliant(drug_x)",
      "-approved(drug_x)",
      "-complete_response(drug_x)",
      "-standard_review(drug_x)"
    ],
    "natural_expressions": [
      "If drug X is approved, then drug X is marketed.",
      "Provided that drug X is approved, drug X is not marketed.",
      "Whenever drug X has orphan drug designation, then if the clinical trial for drug X is complete, it follows that if drug X is approved, then drug X is marketed.",
      "In cases where drug X has orphan drug designation, drug X has a rare disease indication.",
      "Given that drug X has a rare disease indication, then whenever the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed.",
      "Should the clinical trial for drug X be complete, then if drug X is approved, drug X is marketed.",
      "If FDA review of drug X is conducted, then provided the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed.",
      "Either FDA review of drug X is conducted or drug X has fast track designation.",
      "Whenever drug X has fast track designation, then if the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed.",
      "Provided that drug X has fast track designation, drug X has orphan drug designation.",
      "In cases where drug X has fast track designation, drug X has priority review.",
      "If drug X has fast track designation, then drug X has accelerated approval.",
      "Given that drug X has fast track designation, drug X has breakthrough therapy designation.",
      "Should drug X have priority review, then if the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed.",
      "Whenever drug X has accelerated approval, then provided the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed.",
      "If drug X has breakthrough therapy designation, then drug X has accelerated approval.",
      "Provided that drug X has standard review, drug X has a complete response.",
      "If it is not the case that fast track designation of drug X implies breakthrough therapy designation, then drug X has standard review.",
      "In the event that drug X is not manufacturing compliant, drug X is approved.",
      "The clinical trial for drug X is complete.",
      "Drug X is manufacturing compliant.",
      "It is not the case that drug X is approved.",
      "Drug X does not have a complete response.",
      "Drug X does not have standard review."
    ],
    "node_mappings": {
      "(A1 → A2)": {
        "formal": "(A1 → A2)",
        "prover9": "(A1 -> A2)",
        "prover9_expression": "(approved(drug_x) -> marketed(drug_x))",
        "natural": "If drug X is approved, then drug X is marketed."
      },
      "(A1 → ¬A2)": {
        "formal": "(A1 → ¬A2)",
        "prover9": "(A1 -> -A2)",
        "prover9_expression": "(approved(drug_x) -> -marketed(drug_x))",
        "natural": "Provided that drug X is approved, drug X is not marketed."
      },
      "(A11 → (A3 → (A1 → A2)))": {
        "formal": "(A11 → (A3 → (A1 → A2)))",
        "prover9": "(A11 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(orphan_drug_designation(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Whenever drug X has orphan drug designation, then if the clinical trial for drug X is complete, it follows that if drug X is approved, then drug X is marketed."
      },
      "(A11 → A12)": {
        "formal": "(A11 → A12)",
        "prover9": "(A11 -> A12)",
        "prover9_expression": "(orphan_drug_designation(drug_x) -> rare_disease_indication(drug_x))",
        "natural": "In cases where drug X has orphan drug designation, drug X has a rare disease indication."
      },
      "(A12 → (A3 → (A1 → A2)))": {
        "formal": "(A12 → (A3 → (A1 → A2)))",
        "prover9": "(A12 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(rare_disease_indication(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Given that drug X has a rare disease indication, then whenever the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
      },
      "(A3 → (A1 → A2))": {
        "formal": "(A3 → (A1 → A2))",
        "prover9": "(A3 -> (A1 -> A2))",
        "prover9_expression": "(clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x)))",
        "natural": "Should the clinical trial for drug X be complete, then if drug X is approved, drug X is marketed."
      },
      "(A4 → (A3 → (A1 → A2)))": {
        "formal": "(A4 → (A3 → (A1 → A2)))",
        "prover9": "(A4 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(fda_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "If FDA review of drug X is conducted, then provided the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed."
      },
      "(A4 ∨ A5)": {
        "formal": "(A4 ∨ A5)",
        "prover9": "(A4 | A5)",
        "prover9_expression": "(fda_review(drug_x) | fast_track_designation(drug_x))",
        "natural": "Either FDA review of drug X is conducted or drug X has fast track designation."
      },
      "(A5 → (A3 → (A1 → A2)))": {
        "formal": "(A5 → (A3 → (A1 → A2)))",
        "prover9": "(A5 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(fast_track_designation(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Whenever drug X has fast track designation, then if the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
      },
      "(A5 → A11)": {
        "formal": "(A5 → A11)",
        "prover9": "(A5 -> A11)",
        "prover9_expression": "(fast_track_designation(drug_x) -> orphan_drug_designation(drug_x))",
        "natural": "Provided that drug X has fast track designation, drug X has orphan drug designation."
      },
      "(A5 → A6)": {
        "formal": "(A5 → A6)",
        "prover9": "(A5 -> A6)",
        "prover9_expression": "(fast_track_designation(drug_x) -> priority_review(drug_x))",
        "natural": "In cases where drug X has fast track designation, drug X has priority review."
      },
      "(A5 → A7)": {
        "formal": "(A5 → A7)",
        "prover9": "(A5 -> A7)",
        "prover9_expression": "(fast_track_designation(drug_x) -> accelerated_approval(drug_x))",
        "natural": "If drug X has fast track designation, then drug X has accelerated approval."
      },
      "(A5 → A8)": {
        "formal": "(A5 → A8)",
        "prover9": "(A5 -> A8)",
        "prover9_expression": "(fast_track_designation(drug_x) -> breakthrough_therapy(drug_x))",
        "natural": "Given that drug X has fast track designation, drug X has breakthrough therapy designation."
      },
      "(A6 → (A3 → (A1 → A2)))": {
        "formal": "(A6 → (A3 → (A1 → A2)))",
        "prover9": "(A6 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(priority_review(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Should drug X have priority review, then if the clinical trial for drug X is complete, it follows that if drug X is approved, drug X is marketed."
      },
      "(A7 → (A3 → (A1 → A2)))": {
        "formal": "(A7 → (A3 → (A1 → A2)))",
        "prover9": "(A7 -> (A3 -> (A1 -> A2)))",
        "prover9_expression": "(accelerated_approval(drug_x) -> (clinical_trial_complete(drug_x) -> (approved(drug_x) -> marketed(drug_x))))",
        "natural": "Whenever drug X has accelerated approval, then provided the clinical trial for drug X is complete, it implies that if drug X is approved, drug X is marketed."
      },
      "(A8 → A7)": {
        "formal": "(A8 → A7)",
        "prover9": "(A8 -> A7)",
        "prover9_expression": "(breakthrough_therapy(drug_x) -> accelerated_approval(drug_x))",
        "natural": "If drug X has breakthrough therapy designation, then drug X has accelerated approval."
      },
      "(A9 → A10)": {
        "formal": "(A9 → A10)",
        "prover9": "(A9 -> A10)",
        "prover9_expression": "(standard_review(drug_x) -> complete_response(drug_x))",
        "natural": "Provided that drug X has standard review, drug X has a complete response."
      },
      "(¬(A5 → A8) → A9)": {
        "formal": "(¬(A5 → A8) → A9)",
        "prover9": "(-(A5 -> A8) -> A9)",
        "prover9_expression": "(-(fast_track_designation(drug_x) -> breakthrough_therapy(drug_x)) -> standard_review(drug_x))",
        "natural": "If it is not the case that fast track designation of drug X implies breakthrough therapy designation, then drug X has standard review."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-manufacturing_compliant(drug_x) -> approved(drug_x))",
        "natural": "In the event that drug X is not manufacturing compliant, drug X is approved."
      },
      "A3": {
        "formal": "A3",
        "prover9": "A3",
        "prover9_expression": "clinical_trial_complete(drug_x)",
        "natural": "The clinical trial for drug X is complete."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "manufacturing_compliant(drug_x)",
        "natural": "Drug X is manufacturing compliant."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-approved(drug_x)",
        "natural": "It is not the case that drug X is approved."
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-complete_response(drug_x)",
        "natural": "Drug X does not have a complete response."
      },
      "¬A9": {
        "formal": "¬A9",
        "prover9": "-A9",
        "prover9_expression": "-standard_review(drug_x)",
        "natural": "Drug X does not have standard review."
      }
    }
  }
}